Biophytis (Biophytis) Issuance of Debt : $2.05 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Biophytis Issuance of Debt?

Biophytis's Issuance of Debt for the six months ended in Dec. 2023 was $0.00 Mil.

Biophytis's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 was $2.05 Mil.

Biophytis Issuance of Debt Historical Data

The historical data trend for Biophytis's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biophytis Issuance of Debt Chart

Biophytis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Issuance of Debt

Get a 7-Day Free Trial

7.69

10.62

23.15

10.07

2.06

Biophytis Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Issuance of Debt	Get a 7-Day Free Trial															16.57	8.46	1.60	2.05	-

Biophytis Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $2.05 Mil.

Biophytis Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Biophytis's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biophytis (Biophytis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (OTCPK:BPTSY) » Definitions » Issuance of Debt

Comparable Companies

Traded in Other Exchanges

ALBPS:France 6XB:Germany

Address

BC 9, Batiment A 4eme etage, 4 pace Jussieu, Sorbonne University, Paris, FRA, 75005

Website

https://www.biophytis.com

Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.